Antibody-Drug Fusion Constructs for Improved Therapeutic Delivery
Antibody-drug fusion constructs combine targeting specificity of antibodies with therapeutic agents to enhance drug delivery and efficacy. This innovative approach is advancing the antibody drug discovery landscape and driving growth in the Antibody Drug Discovery Market.
These fusion proteins can deliver enzymes, cytokines, or toxins directly to diseased cells, minimizing systemic exposure and side effects. The design of these constructs involves optimizing linker chemistry and ensuring stability and activity of both components.
Applications include cancer therapy, autoimmune diseases, and infectious diseases. Continued research aims to improve targeting accuracy, reduce immunogenicity, and expand the therapeutic repertoire of antibody-drug fusions.